Project Grant HT94252411080
Award Date
9/15/24
Completion Date
9/14/26
Dollars Obligated
$960K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Evanston, IL 60208, USA
Similar Awards
The Northwestern University was awarded a $797,925 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from April 1, 2021 through March 31, 2023 to suppress TDP-43 proteinopathy in mice by targeting RAD-23. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public...
This $640,000 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research by Northwestern University to enhance bispecific antibody therapy with nanoparticle-based photothermal therapy. The project aims to develop innovative approaches to transform healthcare for military service members and the broader public. The research will be conducted at Northwestern University's Sponsored...
This federal Project Grant award of $480,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant was awarded to Northwestern University on September 1, 2024, with a planned completion date of August 31, 2026. The purpose of this grant is to conduct research to uncover the role of translation heterogeneity in ovarian cancer. The grant will support advanced biomedical research initiatives at Northwestern...
This $557,592 federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at Northwestern University to overcome resistance in synovial sarcoma to interferon gamma-mediated immunosensitization. The 3-year project, commencing on November 1, 2024, aims to advance scientific understanding and develop innovative treatments for this rare form of cancer. The research at Northwestern University's...
This federal Project Grant award, valued at $1,306,778 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research focused on investigating the "Immunologic Drivers of Lineage Bias in TP53-mutant Acute Leukemia" at the University of Chicago. The research aims to transform healthcare for military service members and the broader public through innovative and impactful scientific...
This Project Grant award, valued at $293,978.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports research on "Cognition, Vascular Function, and Physical Activity in Multiple Sclerosis" to be conducted by the University of Illinois in Chicago, Illinois. The research aims to explore innovative approaches to disease prevention, diagnosis, treatment, and management of conditions relevant...
This federal Project Grant award, valued at $705,263, was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The funding supports a 3-year research project at Northwestern University to conduct single-cell tracking of the transformation of lung adenocarcinoma to small cell lung cancer. The project aims to generate novel scientific insights and develop innovative approaches to understanding and managing this complex...
This $489,065 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of North Carolina at Chapel Hill to investigate "Potentiated Chip Variants as Therapeutics to Alleviate Tau Pathology and Neurodegeneration." The research aims to develop innovative therapeutic approaches to address neurodegenerative conditions relevant to military service members and the broader public....
The federal Project Grant award in the amount of $925,757.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at Wake Forest University Health Sciences (WFUHS) to selectively reduce repeat expansion RNA with small molecules to treat C9ORF72 mediated amyotrophic lateral sclerosis (ALS). The award, with a period of performance from April 1, 2025 to March 31, 2027, will enable WFUHS, a private non-profit academic...
The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...